Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 61Carcinoma, Renal Cell 39Neoplasm Metastasis 38Neoplasms 24Kidney Neoplasms 20Neuroendocrine Tumors 19Recurrence 16Prostatic Neoplasms 15Head and Neck Neoplasms 13Tuberous Sclerosis 12Triple Negative Breast Neoplasms 12Lymphoma, Mantle-Cell 11Hodgkin Disease 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 10Lymphoma, Large B-Cell, Diffuse 10Lymphoma 10Colorectal Neoplasms 10Waldenstrom Macroglobulinemia 9Stomach Neoplasms 9Multiple Myeloma 9Leukemia, Lymphocytic, Chronic, B-Cell 9Glioma 9Glioblastoma 9Brain Neoplasms 9Sarcoma 8Pancreatic Neoplasms 8Melanoma 8Lymphoma, Follicular 8Lung Neoplasms 8Carcinoma, Non-Small-Cell Lung 8

Interventions

Colonoscopy 4Narrow Band Imaging 2eicosapentaenoic acid ethyl ester 1Ursodeoxycholic Acid 1Telemedicine 1Suppositories 1Selenium 1Radiotherapy 1Propofol 1Ofloxacin 1Midazolam 1Methods 1Folic Acid 1Fentanyl 1Fatty Acids, Omega-3 1Everolimus 1Endoscopic Mucosal Resection 1Endomet 1Doxycycline 1Diet 1Diagnosis 1Cholecalciferol 1Celecoxib 1Calcium Carbonate 1CVD protocol 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Polyps × Everolimus × Clear all
NCT00811590 2024-09-19

Pilot Study of mTOR Inhibitor Therapy in Peutz-Jeghers Syndrome

University of Utah

Phase 2 Terminated
3 enrolled 4 charts

Neoplasms, Peutz-Jeghers Syndrome, Polyps

Data powered by HemOnc (CC BY 4.0) Colophon âš¡